Home > Call For Paper > Cancer and Immunotherapy

Cancer and Immunotherapy

Cancer vaccines and immunotherapy are revolutionary approaches in cancer treatment, stimulating the immune system to recognize and attack cancer cells. Cancer vaccines aim to prevent cancer development or recurrence by leveraging immune responses against specific cancer antigens, while immunotherapy enhances the body's ability to target and destroy cancer cells effectively. These treatments offer promising avenues with potentially fewer side effects than traditional therapies like chemotherapy or radiation. Clinical trials are pivotal in evaluating their safety, efficacy, and optimal dosages, involving rigorous testing on human volunteers under strict regulatory guidelines. Volunteers contribute to advancing medical understanding and healthcare by participating voluntarily in thesetrials. These innovative therapies signify a paradigm shift in cancer care, providing personalized and targeted treatments that hold significant promise in improving patient outcomes and survival rates globally. Through ongoing research and clinical trials, these advancements aim to revolutionize cancer therapy, offering new hope for patients worldwide.

  • Neoantigen Discovery and Targeting
  • Combination Therapies
  • Overcoming Resistance
  • Microbiome Influence
  • Personalized Immunotherapy
  • T Cell Exhaustion and Persistence
  • Oncolytic Virus Therapy
  • Immunotherapy for Rare Cancers
  • Biomarkers and Predictive Models
  • Long-Term Effects and Quality of Life
SUBMIT ABSTRACT
  +1-404-759-9729
Subscribe To Our Newsletter
583324
TOP